Hims(US:HIMS) Prnewswire·2025-06-24 03:55Core Viewpoint - DJS Law Group is investigating Hims & Hers Health, Inc. for potential violations of securities laws following a significant drop in share price due to allegations of illegal practices and misleading marketing [1][2]. Investigation Details - The investigation centers on whether Hims & Hers made misleading statements or failed to disclose critical information to investors [2]. - Novo Nordisk announced the termination of its collaboration with Hims & Hers due to concerns over illegal mass compounding and deceptive marketing practices [2]. - Following the announcement, Hims & Hers shares fell by 31.7% during afternoon trading on June 23, 2025 [2]. Company Background - Hims & Hers Health, Inc. operates in the telehealth sector, focusing on personalized health solutions [2]. - The company has faced scrutiny for its marketing practices and compliance with regulations regarding compounded drugs [2]. Legal Context - DJS Law Group specializes in securities class actions and corporate governance litigation, representing large hedge funds and asset managers [4]. - The firm aims to enhance investor returns through advocacy and legal action [4].